Porte H L, Ernst O J, Delebecq T, Métois D, Lemaitre L G, Wurtz A J
Clinique Chirurgicale, Calmette hospital, Lille, France.
Eur J Cardiothorac Surg. 1999 May;15(5):597-601. doi: 10.1016/s1010-7940(99)00047-0.
This study was undertaken: (1) to evaluate the usefulness of unenhanced computed tomography (CT), magnetic resonance imaging (MRI) and CT guided biopsy for the characterization of adrenal masses in patients with operable non-small-cell lung cancer (NSCLC) and (2) to evaluate the situations in which CT guided biopsy is absolutely necessary before potentially curative resection of NSCLC.
Consecutive patients with operable NSCLC underwent unenhanced adrenal CT with density measurements of any adrenal mass over 1 cm in diameter. An adrenal mass was considered as an adenoma when its density was below 10 Hounsfield Units and a metastasis when its density exceeded 10 Hounsfield Units. Then patients underwent MRI, the signal on the T2 weighted images from the enlarged gland was classified adenoma or metastasis in comparison with that from the liver parenchyma. CT guided biopsy was performed after a pheochromocytoma was eliminated. Unenhanced CT attenuation values and signal intensity values on MRI were correlated with histopathologic results.
Of the 443 patients, 32 had an adrenal mass consisting of adrenal metastases in 18 cases and adenomas in 14 cases. On CT, 3/14 (21%) of the adenomas were misdiagnosed as metastases (their densities exceeded 10 Hounsfield Units) and 2/18 (11%) of the metastases were misdiagnosed as adenomas (their densities were below 10 Hounsfield Units). On MRI, none of the metastases were misdiagnosed as an adenoma (100% sensitivity) but 7/14 (50%) of the adenomas were misdiagnosed as metastases (signal superior to that of liver). Overall, a diagnostic certainty of metastasis could not be obtained in 25/32 patients (78%). CT guided biopsy with 100% sensitivity and specificity corrected all the inaccurate results of CT and MRI without any morbidity.
Despite extensive morphological evaluation with unenhanced CT and conventional MRI, CT guided biopsy is necessary for most patients referred to surgery for an operable NSCLC and an adrenal mass.
开展本研究旨在:(1)评估平扫计算机断层扫描(CT)、磁共振成像(MRI)及CT引导下活检对可手术切除的非小细胞肺癌(NSCLC)患者肾上腺肿块特征的评估价值;(2)评估在NSCLC可能治愈性切除术前CT引导下活检绝对必要的情况。
连续纳入可手术切除的NSCLC患者,对直径超过1 cm的肾上腺肿块进行平扫肾上腺CT并测量密度。当肾上腺肿块密度低于10亨氏单位时考虑为腺瘤,密度超过10亨氏单位时考虑为转移瘤。然后患者接受MRI检查,将增大腺体在T2加权图像上的信号与肝实质信号相比,分为腺瘤或转移瘤。排除嗜铬细胞瘤后进行CT引导下活检。将平扫CT衰减值和MRI信号强度值与组织病理学结果进行相关性分析。
443例患者中,32例有肾上腺肿块,其中肾上腺转移瘤18例,腺瘤14例。CT检查时,14例腺瘤中有3例(21%)被误诊为转移瘤(其密度超过10亨氏单位),18例转移瘤中有2例(11%)被误诊为腺瘤(其密度低于10亨氏单位)。MRI检查时,无转移瘤被误诊为腺瘤(敏感性100%),但14例腺瘤中有7例(50%)被误诊为转移瘤(信号高于肝脏)。总体而言,32例患者中有25例(78%)无法获得转移瘤的明确诊断。CT引导下活检敏感性和特异性均为100%,纠正了所有CT和MRI的不准确结果,且无任何并发症。
尽管采用平扫CT和传统MRI进行了广泛的形态学评估,但对于大多数因可手术切除的NSCLC和肾上腺肿块而转诊手术的患者,CT引导下活检是必要的。